Join the webinar - Cerebrolysin's evidence from TBI research
We are happy to inform you about the new webinar about ‘Cerebrolysin’s evidence from TBI research – Treat early, reduce acute and post-acute complications’. This live webinar will be on 17th April, 2024 from 13:00 – 14:00 CET.
Treating secondary damage symptoms occurring short- and longterm after neurotrauma is an essential task of critical care specialists working in the ER and ICU. Pharmacological agents indicated to save lives after polytrauma or isolated head trauma are globally accepted medications.
Cerebrolysin® can nowadays be included into the globally acknowledged treatment bundles due to the strong evidence provided from the CAPTAIN trials.
Learn more about the role of Cerebrolysin® from the 3 speakers: Bettina Pfausler and Harald Widhalm from Austria and Mark Bayley from Canada! The experts will also discuss how the evidence lead to the inclusion into hospital-internal standard treatment strategies as well as first acknowledgement in important guidelines.
Join the webinar and register here.